Global Peptide API Supply, Demand and Key Producers, 2023-2029

Global Peptide API Supply, Demand and Key Producers, 2023-2029

The global Peptide API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Peptide API production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Peptide API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide API that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Peptide API total production and demand, 2018-2029, (Tons)

Global Peptide API total production value, 2018-2029, (USD Million)

Global Peptide API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)

Global Peptide API consumption by region & country, CAGR, 2018-2029 & (Tons)

U.S. VS China: Peptide API domestic production, consumption, key domestic manufacturers and share

Global Peptide API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)

Global Peptide API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)

Global Peptide API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).

This reports profiles key players in the global Peptide API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AmbioPharm, CordenPharma, Dr. Reddy's, Bachem, Peptide Institute, Inc., PeptiStar, Piramal Pharma, Biosynth and Smaart Pharmaceutticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Peptide API market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Peptide API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Peptide API Market, Segmentation by Type
Hormonal Polyskin
Antibody Polypeptide
Growth Factor Polypeptide
Neuromodulatory Polypeptide
Antibacterial Peptides

Global Peptide API Market, Segmentation by Application
Antineoplastic Drugs
Immune System Drugs
Digestive System Drugs
Diabetes Drugs
Orthopedic Drugs
Obstetric Drugs
Others

Companies Profiled:
AmbioPharm
CordenPharma
Dr. Reddy's
Bachem
Peptide Institute, Inc.
PeptiStar
Piramal Pharma
Biosynth
Smaart Pharmaceutticals
Creative Peptides
CPC Scientific
KS-V
Shenzhen Hanyu Pharmaceutical
Shuangcheng Pharma
Chengdu Shengnuo Biopharm Co.,Ltd

Key Questions Answered

1. How big is the global Peptide API market?

2. What is the demand of the global Peptide API market?

3. What is the year over year growth of the global Peptide API market?

4. What is the production and production value of the global Peptide API market?

5. Who are the key producers in the global Peptide API market?